Awards
30
Seller Intelligence Snapshot
| What this means | Value |
|---|---|
| Dependence on biggest customer | 36.7% (Medium dependence) |
| Dependence on biggest sector | 90.0% (High dependence) |
| Customer concentration score | 2711.1 (High concentration) |
| Sector concentration score | 8200.0 (High concentration) |
Interpretation: a higher concentration score means awards are concentrated in fewer buyers or sectors.
Page 1 of 2 (30 total)
| Title | Status | Buyer | Value | Sector | Source | Published | |
|---|---|---|---|---|---|---|---|
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | complete | Regional Business Services Organisation, Procurement and Logistics Service | £415,333 | Pharmaceutical products | Find a Tender | 12 Jan 2026, 09:49 | View notice |
| NHS National Framework Agreement for Omalizumab | complete | NHS England | £87,433,000 | Pharmaceutical products | Find a Tender | 30 Dec 2025, 16:29 | View notice |
| SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | complete | Western Health & Social Care Trust | £4,638,166 | Pharmaceutical products | Find a Tender | 08 Dec 2025, 12:50 | View notice |
| PRRT (Peptide Receptor Radionuclide Therapy) | complete | Belfast Health & Social Care Trust | £1,820,000 | Medical equipments, pharmaceuticals and personal care products | Find a Tender | 02 Dec 2025, 08:28 | View notice |
| NHS National Framework Agreement for Omalizumab | complete | NHS England | £87,433,000 | Pharmaceutical products | Find a Tender | 28 Nov 2025, 12:23 | View notice |
| SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | complete | Western Health & Social Care Trust | £4,638,166 | Pharmaceutical products | Find a Tender | 10 Nov 2025, 16:36 | View notice |
| SECUKINUMAB 150 mg in 1mL Injection, SECUKINUMAB 300 mg in 2mL Solution for Injection | complete | Western Health & Social Care Trust | £4,638,166 | Pharmaceutical products | Find a Tender | 10 Nov 2025, 15:58 | View notice |
| PRRT (Peptide Receptor Radionuclide Therapy) | complete | Belfast Health & Social Care Trust | £1,820,000 | Medical equipments, pharmaceuticals and personal care products | Find a Tender | 10 Nov 2025, 12:02 | View notice |
| PRRT (Peptide Receptor Radionuclide Therapy) | complete | Belfast Health & Social Care Trust | £1,820,000 | Medical equipments, pharmaceuticals and personal care products | Find a Tender | 10 Nov 2025, 11:56 | View notice |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | complete | NHS England | £52,385,000 | Pharmaceutical products | Find a Tender | 04 Sep 2025, 16:47 | View notice |
| MIDOSTAURIN 25MG CAPSULES | complete | Northern Health And Social Care Trust | £180,000 | Pharmaceutical products | Find a Tender | 03 Sep 2025, 13:34 | View notice |
| Canakinumab | complete | Northern Health And Social Care Trust | £120,000 | Pharmaceutical products | Find a Tender | 03 Sep 2025, 09:22 | View notice |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | complete | NHS England | £22,097,000 | Pharmaceutical products | Find a Tender | 20 Aug 2025, 07:17 | View notice |
| ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL | complete | Northern Health And Social Care Trust | £700,000 | Pharmaceutical products | Find a Tender | 14 Aug 2025, 10:52 | View notice |
| MIDOSTAURIN 25MG CAPSULES | complete | Northern Health And Social Care Trust | £180,000 | Pharmaceutical products | Find a Tender | 13 Aug 2025, 15:27 | View notice |
| MIDOSTAURIN 25MG CAPSULES | complete | Northern Health And Social Care Trust | £180,000 | Pharmaceutical products | Find a Tender | 13 Aug 2025, 15:16 | View notice |
| Canakinumab | complete | Northern Health And Social Care Trust | £120,000 | Pharmaceutical products | Find a Tender | 07 Aug 2025, 14:26 | View notice |
| NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 | complete | NHS ENGLAND | £688,834,174 | Pharmaceutical products | Find a Tender | 01 Aug 2025, 10:49 | View notice |
| NHS National Framework for Transition products (Axitinib and Eltrombopag) | complete | NHS England | £52,385,000 | Pharmaceutical products | Find a Tender | 30 Jul 2025, 10:23 | View notice |
| NHS National Framework for Transition products (Nilotinib and Ticagrelor) | complete | NHS ENGLAND | £22,097,000 | Pharmaceutical products | Find a Tender | 11 Jul 2025, 12:24 | View notice |
Page 1 of 1 (6 buyers)
| Buyer | Award Count | Known GBP | Most Recent Award | Sector Concentration | Opportunities |
|---|---|---|---|---|---|
| Belfast Health & Social Care Trust | 11 | £8,040,000 | 02 Dec 2025, 08:28 | Pharmaceutical products | View notices |
| Northern Health And Social Care Trust | 7 | £1,600,000 | 03 Sep 2025, 13:34 | Pharmaceutical products | View notices |
| NHS England | 5 | £301,733,000 | 30 Dec 2025, 16:29 | Pharmaceutical products | View notices |
| NHS ENGLAND | 3 | £733,028,174 | 01 Aug 2025, 10:49 | Pharmaceutical products | View notices |
| Western Health & Social Care Trust | 3 | £13,914,499 | 08 Dec 2025, 12:50 | Pharmaceutical products | View notices |
| Regional Business Services Organisation, Procurement and Logistics Service | 1 | £415,333 | 12 Jan 2026, 09:49 | Pharmaceutical products | View notices |
Loading competitor overlaps...
| Sector | Notices | Opportunities |
|---|---|---|
| Pharmaceutical products | 27 | View notices |
| Medical equipments, pharmaceuticals and personal care products | 3 | View notices |
| Sector | Known GBP | Notices | Opportunities |
|---|---|---|---|
| Pharmaceutical products | £1,053,271,006 | 27 | View notices |
| Medical equipments, pharmaceuticals and personal care products | £5,460,000 | 3 | View notices |
| CPV Code | Description | Notices | Known GBP | Opportunities |
|---|---|---|---|---|
| 33600000 | Pharmaceutical products | 27 | £1,053,271,006 | View notices |
| 33000000 | Medical equipments, pharmaceuticals and personal care products | 3 | £5,460,000 | View notices |
| Month | Total | Open | Awarded | Known GBP |
|---|---|---|---|---|
| May 2025 | 4 | 0 | 4 | £1,320,000 |
| Jun 2025 | 5 | 0 | 5 | £1,380,000 |
| Jul 2025 | 3 | 0 | 3 | £96,579,000 |
| Aug 2025 | 6 | 0 | 6 | £712,111,174 |
| Sep 2025 | 3 | 0 | 3 | £52,685,000 |
| Nov 2025 | 5 | 0 | 5 | £100,349,333 |
| Dec 2025 | 3 | 0 | 3 | £93,891,166 |
| Jan 2026 | 1 | 0 | 1 | £415,333 |
Months active in last 12: 8. Longest active streak: 5 months.
Known GBP coverage: 100.0% of notices have known GBP values.
Buyer attribution coverage: 100.0% of notices have buyer names populated.